Rana Al-Hajjah, Director of Programs Department, Regional Office for the Eastern Mediterranean, revealed during a press conference today, that the third dose can increase immunity against the Omicron mutant, and there are new vaccines, and the Indian vaccine Novavax has been added to the list of vaccines approved by the World Health Organization, and this Evaluation of vaccines continues continuously until new vaccines.
She said, that companies provide scientific data and that each vaccine must have a special file and that it must be studied extensively, explaining that all these vaccines have not yet been submitted to the World Health Organization, and we generally consider that vaccines are the effective tool for combating diseases and epidemics, explaining that the influenza vaccine protects from influenza.
She added, “There are two influenza vaccines, and we give the children the five-vaccine, and we are in the process of developing vaccines for influenza and corona together, but studies are still under way.”
Ahmed Al-Mandhari, Regional Director for the Eastern Mediterranean, said that companies are cooperating with vaccine manufacturers to transfer technology to provide vaccines at the global level, and there is cooperation with communities and funders.
For his part, Dr. Richard Brennan, Director of Regional Health Emergencies, in the Regional Office for the Eastern Mediterranean, said that despite the increase in Omicron cases, the number of deaths is few, explaining that the high cases in Europe, America and Africa, especially Omicron because it is highly contagious and develops in two or three days compared to Delta which It develops over a longer period, and vaccines protect against hospitalization and deaths, and the increase in cases due to the advent of winter, seasonal flu and hypothermia
.